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Management Decisions in Aortic Regurgitation
Has the Time for Exercise Assessment Finally Arrived?*
Jeffrey S. Borer, MD, FACC
Brooklyn and New York, New YorkAortic regurgitation (AR) is a problem of moderate
but increasing frequency. Current data suggest that
AR of some degree affects approximately 5% to 10%
of the population and increases in frequency and
severity with age (1). When severe, AR gradually leads
to irreversible left ventricular (LV) dysfunction, heart
failure, and death; indeed, sudden death occurs in
asymptomatic patients when intrinsic myocardial dys-
function is severe, even if LV ejection fraction (EF)
See page 48
is normal (2). Aortic valve replacement (AVR) can
reliably minimize or obviate symptoms. However,
management of the asymptomatic patient is a prob-
lem. In the absence of hypertension (3), no evidence
supports “prophylactic” drug therapy for outcome
improvement (4). Inferences from observational
series have led to consensus guidelines defining
indications for AVR (5), but no randomized trials
ever have been performed to rigorously evaluate the
life-prolonging efficacy of surgery, with resulting
uncertainty and controversy. Therefore, current
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the late Stephen Weiss, Greenwich, Connecticut.opinions are based on interpretation of imperfect
data. It seems intuitively reasonable that, because
myocardial damage from exogenous mechanical
overloads is the mediate cause of debility and death
in AR, AVR is appropriate before symptoms de-
velop but when irreversible dysfunction is immi-
nent. But how shall we identify this instant?
Clearly, identifying specific pathogenic myocardial
cellular/molecular processes would be best, but,
despite tantalizing information (6,7), we are far
from data sufficient for this purpose. Thus, for the
best current answer, we must interrogate indices of
myocardial structure and function.
As indicated by Tamas et al. (8) in this issue of
iJACC, the clearest predictors often are apparent too
late. Subnormal LVEF at rest and moderately abnor-
mal LV systolic, and possibly diastolic, dimensions are
relatively reliable predictors of imminent death and
debility (5), but we have no evidence that surgery
performed when these first become apparent will
normalize survival. Rate of progression to these pre-
dictors probably is informative (9), but appropriate
rate-based risk segregators and their accuracy are not
clearly apparent. With the development of radionu-
clide cineangiography more than 3 decades ago (10), it
became practical to employ exercise to unmask poten-
tially important intrinsic myocardial dysfunction that
is not apparent at rest. When first applied to AR, this
approach frequently revealed otherwise unanticipated
abnormalities (11). However, though clearly predic-
tive of outcome (2,9), optimizing the prognostic value
of exercise testing in the unoperated patient required
combining it with echocardiography to normalize EF
for afterload, defining intrinsic contractility (9). Un-
fortunately, the technical requirements of radionuclide
cineangiography have limited its use; other modalities,
including echocardiography, are difficult to apply until
after exercise is completed, altering hemodynamic
loads and resulting functional data. Thus, the poten-
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Editorial Comment
57ial of exercise imaging has not been realized in
outine clinical practice. The work of Tamas et al. (8)
eminds us of the opportunity that is being lost,
emonstrating that myocardial functional reserve gen-
rally improves but may not be normalized by AVR
ven when indexes measured at rest are normal before
peration and that the residual deficit can be predicted
nly from pre-AVR exercise-induced LV perfor-
ance changes (EF). However, the goal of surgery is
ot normalization of LV function but prevention of
linical debility and death. Tamas et al. (8) provide no
nsight into the predictive value of EF for this
urpose, because no clinical follow-up is provided for
heir small series. In addition, their decision to con-
inue medication during testing may have affected
heir results: the drugs employed have multiple phar-
acological effects on the myocardium, some poten-
ially deleterious (4) and possibly altering exercise
esponse. Tamas et al. (8) raise additional questions: If
ystolic function prognostically is most important, but
evelopment of symptoms indicates that AVR has
een excessively delayed, why were both resting and
EF normal in some symptomatic patients? Are
ymptoms related to some other, unmeasured, patho-
hysiological process, or are symptoms, per se, less
rognostically important than previously inferred?
lso, because the Tamas et al. (8) patients with thefor the management of patients with
valvular heart disease: executive sum- 1625–35.ypertension, a known risk marker in AR (4), and
ecause hypertension persisted after surgery, the func-
ional reserve deficit in this group may have been more
elated to afterload than to intrinsic myocardial dys-
unction both before and after AVR. Responses to
ome of these issues are provided by recent preliminary
ata from our ongoing study of the natural history of
R and its predictors (12): among multiple com-
only employed clinical, echocardiographic, and ra-
ionuclide cineangiography descriptors, long-term
urvival after AVR is, indeed, best predicted by EF
hen it is adjusted for afterload, independent of
ymptoms—and mortality excess, compared with the
ge- and sex-matched U.S. census cohort, begins with
isturbingly modest contractility deficits. The latter find-
ng highlights the need for continuing evaluation of the
dequacy of current consensus indications for surgery.
With recent technical advances, methods other
han radionuclide cineangiography may now enable
ollection of the relevant data. However, as Tamas et al.
8) remind us, the well-established method remains
iable and, far more importantly, it is high time to accept
he utility of exercise-induced LV functional changes in
anagement decision making for patients with AR.
eprint requests and correspondence: Dr. Jeffrey S. Borer,
7 East 88th Street, New York, New York 10128-1152.ost markedly subnormal EF were those with E-mail: canadad45@aol.com.1
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